Nuclear receptor 4A3

Nuclear receptor 4A3 (NR4A3), also known as NOR-1 (neuron-derived orphan receptor 1), is a protein that in humans is encoded by the NR4A3 gene. This nuclear receptor is a part of the NR4A subfamily of the nuclear receptor superfamily of transcription factors. NR4A3 plays a significant role in various physiological processes, including metabolism, inflammation, and the development of the central nervous system. It is also implicated in several pathologies, such as cancer, cardiovascular diseases, and metabolic disorders.

Function

NR4A3 is a transcription factor that is rapidly induced in response to a wide range of stimuli, including growth factors, inflammatory signals, and stress signals. It functions as an early response gene, modulating the expression of downstream genes involved in cell proliferation, apoptosis, and differentiation. NR4A3 can act as a transcriptional activator or repressor, depending on the cellular context and the presence of co-regulators. Its activity is modulated through post-translational modifications, such as phosphorylation, and interactions with other proteins.

Gene and Expression

The NR4A3 gene is located on chromosome 9q22. It is expressed in various tissues, with high levels observed in the brain, skeletal muscle, and heart. Expression of NR4A3 is tightly regulated, and its dysregulation has been associated with several diseases. In the nervous system, NR4A3 is involved in neuronal development and plasticity. In the immune system, it plays a role in the regulation of inflammatory responses.

Clinical Significance

Alterations in the expression or function of NR4A3 have been linked to a range of diseases. In cancer, NR4A3 can act as a tumor suppressor or an oncogene, depending on the type of cancer. Its overexpression has been observed in certain leukemias, while its downregulation is associated with prostate and breast cancers. In cardiovascular diseases, NR4A3 is involved in the regulation of vascular inflammation and the response to vascular injury. Its role in metabolism includes the regulation of glucose and lipid homeostasis, making it a potential target for the treatment of metabolic disorders such as diabetes and obesity.

Interaction with Other Proteins

NR4A3 interacts with various proteins that modulate its activity and function. These include co-activators and co-repressors that influence its transcriptional activity, as well as other transcription factors with which it may form heterodimers. The interaction with these proteins can significantly affect the cellular response to external stimuli, influencing cell fate decisions.

Potential Therapeutic Target

Given its involvement in multiple key physiological processes and diseases, NR4A3 presents a potential therapeutic target. Modulating its activity could offer new avenues for the treatment of diseases such as cancer, cardiovascular diseases, and metabolic disorders. Small molecule modulators of NR4A3 are being explored for their therapeutic potential.

See Also

• Nuclear receptor
• Transcription factor
• Metabolism
• Inflammation
• Cancer
• Cardiovascular disease
• Metabolic disorder

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian